Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2303835Generated: November 1, 2026

Triethylamine → N-[4-[2-[4-(2,4-dioxothiazolidin-5-ylmethyl)phenoxymethyl]-1-methyl-1H-benzimidazol-6-yloxy]phenyl]cyclopentanecarboxamide

https://huagongshe.com/reaction/2303835

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTriethylamineHCID 8471—
ReactantEthyl chloroformateHCID 10928—
ReactantCyclopentanecarboxylic acidHCID 18840—
Reactant5-[4-[6-(4-aminophenoxy)-1-methyl-1H-benzimidazol-2-ylmethoxy]benzyl]thiazolidine-2,4-dione dihydrochlorideHCID 86587768—
SolventWaterHCID 962—
SolventDimethylformamideHCID 6228—
ProductN-[4-[2-[4-(2,4-dioxothiazolidin-5-ylmethyl)phenoxymethyl]-1-methyl-1H-benzimidazol-6-yloxy]phenyl]cyclopentanecarboxamideHCID 1021005956.6%

Reaction Steps

Ethyl chloroformate (87 mg) was added dropwise to a solution of cyclopentanecarboxylic acid (90 mg) and triethylamine (232 mg) in anhydrous N,N-dimethylformamide (8 ml) at ambient temperature. The mixture was stirred at the same temperature for 1.5 hours. To the reaction mixture was added 5-{4-[6-(4-aminophenoxy)-1-methyl-1H-benzimidazole-2-ylmethoxy]benzyl}thiazolidine-2,4-dione dihydrochloride (400 mg) in small portions. The mixture was stirred at ambient temperature for 5 hours and allowed to stand at the same temperature overnight. After concentration of the mixture, water was added to the reaction mixture and the insoluble product was isolated by filtration and washed with water and ethyl acetate to give the title compound (236 mg).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06432993B1
Source datasetuspto-grants-2002_08
ORD IDord-c3694f10ec134c1b9d70062f5dab9234
Source noteuspto-grants-2002_08